As of March 2026 Cadrenal Therapeutics has a market cap of A$22.88 Million. This makes Cadrenal Therapeutics the world's 10250th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 19th, 2026 the market cap of Cadrenal Therapeutics was reported to be: